AC
ASB Consultores’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,110
| Closed | -$232K | – | 138 |
|
|
2024
Q4 | $232K | Buy |
+4,110
| New | +$232K | 0.1% | 183 |
|
|
2024
Q2 | – | Sell |
-8,200
| Closed | -$445K | – | 208 |
|
|
2024
Q1 | $445K | Buy |
+8,200
| New | +$445K | 0.11% | 130 |
|
|
2023
Q4 | – | Sell |
-7,361
| Closed | -$427K | – | 120 |
|
|
2023
Q3 | $427K | Sell |
7,361
-3,235
| -31% | -$188K | 0.17% | 57 |
|
|
2023
Q2 | $678K | Buy |
10,596
+310
| +3% | +$19.8K | 0.33% | 60 |
|
|
2023
Q1 | $713K | Buy |
10,286
+1,561
| +18% | +$108K | 0.29% | 45 |
|
|
2022
Q4 | $628K | Buy |
8,725
+519
| +6% | +$37.3K | 0.26% | 46 |
|
|
2022
Q3 | $583K | Buy |
8,206
+588
| +8% | +$41.8K | 0.27% | 44 |
|
|
2022
Q2 | $587K | Buy |
7,618
+116
| +2% | +$8.94K | 0.26% | 42 |
|
|
2022
Q1 | $548K | Sell |
7,502
-548
| -7% | -$40K | 0.23% | 72 |
|
|
2021
Q4 | $502K | Buy |
+8,050
| New | +$502K | 0.25% | 80 |
|